Pharmacotherapy costs of osteoporosis and related fractures in Bulgaria
thumbnail.default.placeholder
Дата
2012-04
Автори
Savova, A.
Stoimenova, A.
Manova, M.
Petrova, G.
Заглавие на списанието
ISSN на списанието
Заглавие на тома
Издател
Централна медицинска библиотека, МУ София / Central Medical Library - MU Sofia
Резюме
The objective of the study is to investigate and calculate the direct
medical costs of osteoporosis, the indirect ones, as well as the family costs in Bulgaria.
A top down retrospective cost study has been developed. Epidemiology data
for osteoporosis has been derived from two published reports. The information on
the prices of medicines, patient co-payment, level of reimbursement, hospitalization
cost and average hospital stay is based on the offi cial national sources. Offi cial
information provided by the National Health Insurance Fund is that in 2009 only
2,143,046 BGN for 5,950 treated patients were paid. The annual cost of femoral
fractures should be 8 million BGN, and 800,000 BGN for rehabilitation. The rest
of the fractures are mild and account for 26,950,000 BGN. The average disability
loses account for approximately 23,105,472 BGN. The direct medical cost exhibits
the proportion of 2 million for medicines to 36 million BGN for treatment of fractures.
The major conclusions from our analysis are that the patients with osteoporosis in
Bulgaria are not adequately treated in terms of reimbursement coverage and patients
carry the greater part of fi nancial and social burden.
Описание
Address for correspondence:
A. Savova ; Faculty of Pharmacy, Department
of Social Pharmacy and Pharmacoeconomics
Medical University; 2 Dunav Str.;
1000 Sofia, Bulgaria;
e-mail: alex_savov@mail.bg
Ключови думи
cost study, pharmacotherapy, osteoporosis, health policy, medicines policy
Цитирания
A. Savova, A. Stoimenova, M. Manova and G. Petrova. Pharmacotherapy costs of osteoporosis and related fractures in Bulgaria - Acta medica bulgarica , 39, 2012, No 1, 31- 39.